Targeting of glycosylated lipoplexes in HepG2 cells: Anomeric and C-4 epimeric preference of the asialoglycoprotein receptor

South African Journal of Science

Volumn 103, Issue 5-6, 2007, Pages 204-210

  Singh, Moganavelli ^a   Rogers, Colin B ^a   Ariatti, Mario ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CELL ORGANELLE; DNA; ENZYME ACTIVITY; GENE TRANSFER; LIGAND; LIPID; MEMBRANE; PROTEIN; TRANSMISSION ELECTRON MICROSCOPY;

INSECTIVORA;

EID: 36148998416     PISSN: 00382353     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Saxena A., Yik J.H. and Weigel P.H. (2002). H2, the minor subunit of the human asialoglycoproteinreceptor trafficks intracellularly and forms homo-oligomers, but does not bind asialo-orosomucoid. J. Biol. Chem. 277, 35297-35304.
2. Schwartz A.L., Fridovich S.E., Knowles B.B. and Lodish H.F. (1981). Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J. Biol. Chem. 256, 8878-8881.
3. Knowles B.B., Howe C.C. and Aden D.P. (1980). Human hepatocellular carcinoma cell lines secrete the major plasma proteins on hepatitis B surface antigen. Science 209, 497-499.
4. Wu G.Y. and Wu C.H. (1987). Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262, 4429-4432.
5. Wu G.Y. and Wu C.H. (1988). Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. 263, 14621-14624.
6. Mack K.D., Walzen R. and Zeldis J.B. (1994). Cationic lipid enhances in vitro receptor-mediated transfection. Am. J. Med. Sci. 307, 138-143.
7. Cho C-W., Cho Y-S., Lee H-K., Yeom Y.I., Park S-N. and Yoon D-Y. (2000). Improvement of receptor-mediated gene delivery to HepG2 cells using an amphiphilic gelling agent. Biotechnol. Appl. Biochem. 32, 21-26.
8. Singh M., Kisoon N. and Ariatti M. (2001). Receptor-mediated gene delivery to HepG2 cells by ternary assemblies containing cationic liposomes and cationized asialoorosomucoid. Drug Deliv. 8, 29-35.
9. Singh M. and Ariatti M. (2003). Targeted gene delivery into HepG2 cells using complexes containing DNA, cationized asialoorosomucoid and activated cationic liposomes. J. Control. Release 92, 383-394.
10. Han J., Lim M. and Yeom Y.I. (1999). Receptor-mediated gene transfer to cells of hepatic origin by galactosylated albumin-polylysine complexes. Biol. Pharm. Bull. 22, 836-840.
11. Chen J., Stickles R.J. and Daichendt K.A. (1994). Galactosylated histone-mediated gene transfer and expression. Hum. Gene Ther. 5, 429-435.
12. Niidome T., Urakawa M., Sato H., Takahara Y., Anai T., Hatakayama T., Wada A., Hirayama T. and Aoyagi H. (2000). Gene transfer into hepatoma cells mediated by galactose-modified α-helical peptides. Biomaterials 21, 1811-1819.
13. Han J. and Yeom Y.I. (2000). Specific gene transfer mediated by galactosylated poly-L-lysine into hepatoma cells. Int. J. Pharm. 202, 151-160.
14. Hashida M., Takemura S., Nishikawa M. and Takakura Y. (1998). Targeted delivery of plasmid DNA complexed with galactosylated poly (L-lysine). J. Control. Release 53, 301-310.
15. Plank C., Zoutlakal K., Cotton M., Mechtler K. and Wagner E. (1992). Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjugate Chem. 3, 533-539.
16. Hisayasu S., Miyanchi M., Akiyama K., Gotoh T., Satoh S. and Shimada T. (1999). In vivo gene transfer into liver cells mediated by a novel galactosyl-D-lysine/D-serine copolymer. Gene Therapy 6, 689-693.
17. Bettinger T., Remy J-S. and Erbacher P. (1999). Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes. Bioconjugate Chem. 10, 558-561.
18. Ren T., Zhang G. and Liu D. (2001). Synthesis of galactosyl compounds for targeted gene delivery. Bioorgan. Med. Chem. 9, 2969-2978.
19. Remy S-J., Kichler A., Mordvinov V., Schuber F. and Behr, J-P. (1995). Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage towards artificial viruses. Proc. Natl Acad. Sci. USA 92, 1744-1748.
20. Gao S., Chen J., Xu X., Ding Z., Yang Y-H., Hua Z. and Zhang, J. (2003). Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int. J. Pharm. 255, 57-68.
21. Biessen E.A.L., Veitsch H. and van Berkel T.J.C. (1994). Cholesterol derivative of a new triantennary cluster galactoside directs low- and high density lipoproteins to parenchymal cells. Biochem. J. 302, 283-289.
22. Kawakami S., Yamashita F., Nishikawa M., Takakura Y. and Hashida M. (1998). Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Biochem. Biophys. Res. Commun. 252, 78-83.
23. Sun X., Hai L., Wu Y., Hu H.Y. and Z.R. Zhang. (2005). Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD). J. Drug Target. 13, 121-128.
24. Wu J., Nantz M.H. and Zern M.A. (2002). Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front. Biosci. 7, 717-725.
25. Singh M. and Ariatti M. (2006). A cationic cytofectin with long spacer mediates favourable transfection in transformed human epithelial cells. Int. J. Pharm. 309, 189-198.
26. Rogers C.B. and Thevan I. (1986). Identification of mollic acid α-L-arabinoside, a 1-α-hydroxycycloartenoid from Combretum molle leaves. Phytochemistry 25, 1759-1761.
27. Seo S., Tomita Y., Tori K. and Yoshimura Y. (1978). Determination of the absolute configuration of a secondary hydroxyl group in a chiral secondary alcohol using glycosidation shifts in carbon-13 nuclear magnetic resonance spectroscopy. J. Am. Chem. Soc. 100, 3331-3339.
28. Le Pecq J-B. and Paoletti C. (1967). A fluorescent complex between ethidium bromide and nucleic acids. J. Mol. Biol. 27, 87-106.
29. Gaell A.J. and Blagbrough I.S. (2000). Rapid and sensitive ethidium bromide fluorescence quenching assay of polyamine conjugate-DNA interactions for the analysis of lipoplex formation in gene therapy. J. Pharm. Biomed. Anal. 22, 849-859.
30. Tros de Ilarduya C., Arangoa M.A., Moreno-Aliaga M.J. and Düzgüneş, N. (2002). Enhanced gene delivery in vitro and in vivo by improved transferrin-lipoplexes. Biochim. Biophys. Acta 1561, 209-221.
31. Schellekens H. and Stitz, L.W. (1980). Simple method for measuring growth inhibition by interferon of cells in monolayer. J. Virol. Meth. 1, 197-200.
32. Wimmer Z., Pechová L. and Šaman, D. (2004). Koenigs-Knorr synthesis of cycloalkyl glycosides. Molecules 9, 902-912.
33. Agrawal, P.K. (1992). NMR spectroscopy in the structural elucidation of oligosaccharides and glycosides. Phytochemistry 31, 3307-3330.
34. Ren T., Zhang G. and D. Liu. (2001). Synthesis of galactosyl compounds for targeted gene delivery. Bioorgan. Med. Chem. 9, 2969-2978.
35. Davis B.G. and Robinson M.A. (2002). Drug delivery systems based on sugar-macromolecule conjugates. Curr. Opin. Drug Discov. Devel. 5, 279-288.
36. Managit C., Kawakami S., Yamashita F. and Hashida M. (2005). Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes. J. Pharm. Sci. 94, 2266-2275.
37. Hattori Y., Suzuk, S., Kawakami S., Yamashita F. and Hashida M. (2005). The role of phosphatidylerhanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. J. Control. Release 108, 484-495.
38. Felgner J.H. Kumar R., Sridhar C.N., Wheeler C.J., Tsai Y.J., Border R., Ramsey P., Martin M. and. Felgner P.L. (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269, 2550-2561.
39. Percot A., Briane D., Coudet R., Reynier P., Bouchemal N., Lievre N., Hantz E., Salzmann J.L. and Cao A. (2004). A hydroxyethylated cholesterol-based cationic lipid for DNA delivery: effect of conditioning. Int. J. Pharm. 278, 143-163.
40. Schätzlein A.G. (2003). Targeting of synthetic gene delivery systems. J. Biomed. Biotechnol. 2, 149-158.
41. Wattiaux R., Laurent N., Wattiaux-DeConinck S. and Jadot M. (2000). Endosomes, lysosomes: their implication in gene transfer. Adv. Drug Deliv. Rev. 41, 201-208.
42. Pun S.H. and Davis M.E. (2002). Development of nonviral gene delivery vehicle for systemic application, Bioconjugate Chem. 13, 630-639.
43. Zanta M.A., Boussif O., Adib A. and Behr J.P. (1997). In vitro gene delivery to hepatocytes with galactosylated polyethyleneimine. Bioconj. Chem. 8, 839-844.
44. Higuchi Y., Kawakami S., Fumoto S., Yamashita F. and Hashida M. (2006). Effect of the particle size of galactosylated lipoplex on hepatocyte-selective gene transfection after intraportal administration. Biol. Pharm. Bull. 29, 1521-1523.
45. Fumoto S., Nakadori F., Kawakami S., Nishikawa M., Yamashita F. and Hashida, M. (2003). Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver. Pharmaceut. Res. 20, 1452-1459.